跳至主要内容
临床试验/NCT04527861
NCT04527861招募中不适用

Oncologic Outcomes of Single-incision Laparoscopic Surgery Versus Conventional Laparoscopic Surgery for Colorectal Cancer: A Multi-center, Prospective, Open Label, Non-inferiority, Randomized Controlled Trial

Ruijin Hospital12 个研究点 分布在 1 个国家目标入组 710 人开始时间: 2021年4月8日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
710
试验地点
12
主要终点
3-year disease free survival rate

研究概览

简要总结

This study is designed to investigate long-term oncologic outcomes of single-incision laparoscopic surgery (SILS) compared to conventional laparoscopic surgery (CLS) for colorectal cancer.

详细描述

In order to improve cosmetic effect and reduce postoperative pain, single-incision laparoscopic surgery (SILS) is attracting increasing attention. SILS is considered to be the next major advance in the progress of minimally invasive surgical approaches to colorectal disease that is more feasible in generalized use. In most previous studies, SILS for colorectal cancer was feasible and short-term safe compared to conventional laparoscopic surgery (CLS) . However, there is still controversy over its potential better cosmetic effect and less postoperative pain. Moreover, the long-term oncologic outcomes are still inconclusive as only a few studies showed long-term survival data. Up to now, most studies were limited to their retrospective nature and small samples. So more studies, especially large-scale, randomized controlled trials are needed to establish the best indications for SILS for colorectal cancer.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years < age ≤85 years
  • Tumor located in colon and high rectum ( the lower border of the tumor is above the peritoneal reflection)
  • Pathological or highly suspected colorectal carcinoma
  • Clinically diagnosed cT1-4aN0-2 M0 lesions according to the 8th Edition of AJCC Cancer Staging Manual
  • Tumor size of 5 cm or less
  • ECOG score is 0-1
  • ASA score is Ⅰ-Ⅲ
  • Informed consent

排除标准

  • Body mass index (BMI) >35 kg/m2
  • The lower border of the tumor is located distal to the peritoneal reflection
  • Familial adenomatous polyposis (FAP)
  • Inflammatory bowel disease (IBD)
  • Multiple malignant colorectal tumors
  • Pregnant woman or lactating woman
  • Severe mental disease
  • Previous gastrointestinal surgery (except appendectomy )
  • Emergency operation due to complication (bleeding, perforation or obstruction) caused by colorectal cancer
  • Requirement of simultaneous surgery for other disease
  • Simultaneous or metachronous multiple cancers with disease-free survival ≤ 5 years

结局指标

主要结局

3-year disease free survival rate

时间窗: 36 months after surgery

3-year disease free survival rate

次要结局

  • Operative time(intraoperative)
  • Incision length(intraoperative)
  • Intraoperative blood loss(intraoperative)
  • Total incision length(intraoperative)
  • Conversion rate(intraoperative)
  • Early morbidity rate(30 days after surgery)
  • Lymph node detection(14 days after surgery)
  • Length of stay(1-14 days after surgery)
  • Tumor size(14 days after surgery)
  • Cosmetic effect(1 month, 6 months and 1 year after surgery)
  • The quality of life-Colorectal(1 month, 6 months and 1 year after surgery)
  • Postoperative recovery course(1-14 days after surgery)
  • Pain score(1-3 days after surgery)
  • Incisal margin(14 days after surgery)
  • The quality of life-Core(1 month, 6 months and 1 year after surgery)
  • 5-year overall survival rate(60 months after surgery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Zhao Ren

Chief Physicion

Ruijin Hospital

研究点 (12)

Loading locations...

相似试验